ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 28 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 180 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 180 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 180 | -92.7% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 2,450 | -1.5% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 2,488 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -80.0% | 2,488 | -44.1% | 0.00% | – |
| Q2 2017 | $5,000 | -28.6% | 4,452 | +0.0% | 0.00% | – |
| Q1 2017 | $7,000 | +75.0% | 4,450 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -50.0% | 4,450 | -31.0% | 0.00% | – |
| Q3 2016 | $8,000 | -42.9% | 6,450 | -13.4% | 0.00% | – |
| Q2 2016 | $14,000 | +180.0% | 7,450 | +204.1% | 0.00% | – |
| Q1 2016 | $5,000 | -93.8% | 2,450 | -90.2% | 0.00% | – |
| Q4 2015 | $81,000 | – | 25,000 | +22627.3% | 0.00% | – |
| Q3 2015 | $0 | – | 110 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 90,000 | $222,000 | 0.17% |
| EQUITEC SPECIALISTS, LLC | 21,820 | $54,000 | 0.02% |
| TFS CAPITAL LLC | 46,886 | $116,000 | 0.01% |
| Westend Capital Management, LLC | 1,000 | $3,000 | 0.00% |
| A.R.T. Advisors, LLC | 33,414 | $82,000 | 0.00% |
| Virtu KCG Holdings LLC | 31,765 | $78,000 | 0.00% |
| RHUMBLINE ADVISERS | 14,080 | $35,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,115 | $2,754,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,489 | $374,000 | 0.00% |
| BlackRock Investment Management, LLC | 73,717 | $182,000 | 0.00% |